Bing

SEARCH HISTORY

New York, NY - (ACCESSWIRE) - 10/29/2013 - Equity Profile Report initiates its NASDAQ Active Stock Watch List adding American Capital Agency Corp. (NASDAQ:AGNC), Patterson-UTI Energy Inc. (NASDAQ:PTEN), Amgen Inc. (NASDAQ:AMGN), and …
4 Traders · 10/29/2013
In what is on par with the course in today’s stock market, biotechnology firm Amgen Inc. (AMGN) posted double-digit revenue and earnings growth while raising its full-year outlook. The kicker for this stock and its recent price strength was the news that ...
Trefis · 8/5/2014
Following are the list of events of various biotech companies that investors should closely watch this month: Amgen, Inc. (NASDAQ: AMGN), the largest biotechnology company in the World, is expected to conduct an analyst day on Feb.7. The company is ...
istock Analyst · 2/5/2013
More from Bing News
June 8, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Goldman Sachs Global Healthcare ... For more information, visit www.amgen.com and follow us on www.twitter.com/amgen. Stock Market XML and JSON Data API provided by …
Financial Content · 6/8/2015
Amgen
You make money either if the stock price makes a large move away from its current price or if the market’s expectations for a large move increase and add value to the options. It’s Oct. 2, 2006. Amgen (NasdaqGS: AMGN) will report earnings in a few ...
Investing Daily · 7/15/2010
Expedia Inc (NASDAQ:EXPE) is 3.8% higher at $97.76 -- and earlier notched a fresh all-time high of $98.31 -- after Cowen and Company raised its price target on the stock to $115 from ... Inc.'s (NASDAQ:AMGN) Seattle waterfront property(subscription ...
Schaeffer's Investment Research · 4/2/2015
Biotechnology stocks Gilead Sciences (GILD), Amgen (AMGN) and Biogen (BIIB) were at the crest of Thursday’s stock rally, powering the largest biotech exchange-traded fund to a fresh record high. One technical analyst says Thursday’s decisive rush ...
Barron's · 6/18/2015
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among …
YCharts · 12/31/2014
Moreover, nearly 75 percent of biotechs in the Nasdaq Biotech Index have no earnings at all and just five companies -- Gilead (GILD), Amgen (AMGN), Shire (SHPG ... for everyone because a big part of the stock market -- as illustrated by the NYSE …
CBS News · 3/25/2015
Traders work on the floor of the New York Stock ... Amgen's (AMGN ) current ratio of 4.2 may not be as good as Celgene's, but it's still among the best in the industry, and that fact, along with Amgen's distinction of being one of the few biotech stocks ...
USA Today · 1/18/2015

Amgen

Company
Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Locate…
Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotechnology firm. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.
Data from: Wikipedia